Abivax

ABVX NASDAQ Santé & Biotech Europe US00370M1036
99.34 $
1.60 %

Abivax développe des traitements pharmaceutiques pour les maladies inflammatoires, virales et immuno-oncologiques.

Performance & Momentum

6 Months 22.87 %
1 Year 1 149 %
3 Years 1 085 %
5 Years 1 085 %

Similar stocks to Abivax

Anantys Community

Be the first to share your analysis on Abivax.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases